Glenmark Pharmaceuticals stock: dividend
GLENMARK.NSGlenmark Pharmaceuticals paid $0.03 per share over the last twelve months, 0.09% on the price, and has not cut its dividend for 17 years.
Daily figure as of 13 Nov 2026
The amounts for the last 12 months and for fiscal 2026 differ if the company has raised or cut its dividend since then.
Dividend dates and payments
Anyone holding the stock on the day before the ex-dividend date receives the dividend. Amounts are per share, before tax.
All 6 payments of the last five years
| Ex-dividend date | Payment date | Dividend per share |
|---|---|---|
| 31 Aug 2026 | 11 Oct 2026 | $0.0266 |
| 3 Oct 2025 | 26 Oct 2025 | $0.0266 |
| 15 Sep 2025 | 26 Oct 2025 | $0.0266 |
| 13 Sep 2024 | 27 Oct 2024 | $0.0266 |
| 18 Sep 2023 | 29 Oct 2023 | $0.0266 |
| 12 Sep 2022 | 27 Oct 2022 | $0.0266 |
Is today's dividend yield unusually high?
Dividend yield today
0.09%
lower than in recent years$0.027 dividend per share over the last twelve months on a price of $28.27
Today 0.09%, on average over fiscal years 2017 to 2026 0.34% (range 0.12 to 1.21%). That is lower than in each of the last 10 fiscal years.
Since the end of fiscal 2026 on 31 Mar 2026, the price has risen, so the yield has fallen.
- Fiscal year
- Today, last 12 months
For each fiscal year, the dividend per share for that year divided by the closing price on the last trading day of the fiscal year. The dashed line is the average (median) of the fiscal years.
Dividend development
Dividend per share
Payout ratio
- of earnings
- of free cash flow
Figures as a table
| Year | Dividend per share | Earnings per share |
|---|---|---|
| 2007 | $0.0117 | $0.14 |
| 2009 | $0.0043 | $0.08 |
| 2010 | $0.0043 | $0.13 |
| 2011 | $0.0043 | $0.18 |
| 2012 | $0.0213 | $0.18 |
| 2013 | $0.0213 | $0.24 |
| 2014 | $0.0213 | $0.21 |
| 2015 | $0.0213 | $0.19 |
| 2016 | $0.0213 | $0.27 |
| 2017 | $0.0213 | $0.34 |
| 2018 | $0.0213 | $0.30 |
| 2019 | $0.0213 | $0.35 |
| 2020 | $0.0266 | $0.29 |
| 2021 | $0.0266 | $0.37 |
| 2022 | $0.0266 | $0.35 |
| 2023 | $0.0266 | −$0.06 |
| 2024 | $0.0266 | −$0.72 |
| 2025 | $0.0266 | $0.39 |
| 2026 | $0.0266 | $0.51 |
The dividend per share is shown under the fiscal year it was paid for, even when it is paid after that year ends. Special dividends are not included.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₹94.0836)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 31 Jul 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.